It works by mimicking two naturally occurring hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which play essential roles in regulating appetite and metabolizing glucose
As a result, the demand for skincare and hair care products containing these ingredients is escalating as consumers seek to replenish and maintain optimal levels to combat the effects of ageing and maintain healthy, youthful-looking skin and hair
But the team over there told me its in the works, just not quite finished yet
In terms of valuation, Eli Lilly's PE - TTM on June 24 was 66x
Nutrition Vital When Taking GLP-1 Weight Loss Drugs. UCHealth Today, 19 May 2025
Manufacturing Capacity and Supply Chain Investment: In a bid to avoid previous shortages of injectable GLP-1s, Eli Lilly has amassed a $1.5 billion pre-launch inventory of its oral weight loss drug orforglipron ahead of FDA decision expected in April 2026 [4]